- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Edmund Power is counsel in King & Spalding’s Special Matters and Investigations practice.
Edmund is an experienced trial attorney and investigator who represents companies and individuals in government and corporate investigations and related criminal and regulatory matters. He has significant experience defending clients in matters involving federal and state False Claims Acts, the Foreign Corrupt Practices Act, and in investigations brought by the U.S. Department of Justice and Securities and Exchange Commission.
From 2003 to 2010, Edmund was a federal prosecutor, first with the Criminal Enforcement Section of the U.S. Department of Justice’s Tax Division and then as an Assistant U.S. Attorney with the United States Attorney's Office for the Eastern District of Virginia.
In these roles, Edmund led investigations that resulted in the convictions of more than 100 individuals and entities for felony offenses. He also successfully conducted 11 jury trials, including those of a former SEC enforcement attorney for conspiracy to commit securities fraud, of a mortgage broker and CPA for mortgage fraud, and of a Northern Virginia crime family for racketeering.
Before beginning his legal career, Edmund served as an infantry officer in the United States Marine Corps and attained the rank of Captain.
Credentials
J.D., Washington and Lee University School of Law, magna cum laude
B.A., College of the Holy Cross, cum laude
District of Columbia
U.S. District Court for the Eastern District of Virginia
Virginia
Matters
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
See more
Close
Matters
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
Represented an international financial institution as local counsel during criminal proceedings in the Eastern District of Virginia.
Represented a financial institution in a multi-district litigation relating to the alleged manipulation of foreign currency exchange rates.
Represented the executives and managers of the Indian subsidiary of a listed U.S. company in connection with DOJ and SEC FCPA investigations.
Insights
Article · Source: Law360
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
Client Alert
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
Client Alert
October 16, 2019
DOJ Issues Guidance for Evaluating a Business Organization's Inability to Pay a Criminal Fine or Penalty
Matters
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
See more
Close
Matters
Represented a publicly traded medical device manufacturer during a jury trial and acquittal on federal criminal charges relating to “off-label” marketing.
Represented an international shipping company in resolving False Claims Act qui tam litigation with the federal government and 17 state attorneys general.
Represented the former CEO of a regenerative medicine company in providing testimony to the SEC.
Represented an international financial institution as local counsel during criminal proceedings in the Eastern District of Virginia.
Represented a financial institution in a multi-district litigation relating to the alleged manipulation of foreign currency exchange rates.
Represented the executives and managers of the Indian subsidiary of a listed U.S. company in connection with DOJ and SEC FCPA investigations.
Insights
Article · Source: Law360
March 3, 2020
Foreign Influence Lessons From Research Org FCA Deal
Client Alert
February 25, 2020
DOJ Announces FCA Settlement with NIH-Funded Institute Related to Disclosure of Foreign Influence in Research
Client Alert
October 16, 2019
DOJ Issues Guidance for Evaluating a Business Organization's Inability to Pay a Criminal Fine or Penalty
Credentials
J.D., Washington and Lee University School of Law, magna cum laude
B.A., College of the Holy Cross, cum laude
District of Columbia
U.S. District Court for the Eastern District of Virginia
Virginia